Guardant Health
GH
168.33
-2.36
-1.38%
Guardant Health
US · GH
#820 by market cap
Listed 2018
168.33
-2.36
-1.38%
Live - 5344 symbols - heartbeat 171s ago
· 2026-10-08 07:03
Pre-market
168.33
0.00%
After-hours
168.33
0.00%
Overnight
167.98
-0.21%
- Market cap
- 22.59B
- P/E (TTM)i
- -47.96
- P/Bi
- -101.34
- EPSi
- -3.32
- Div yieldi
- 0.00%
- 52W posi
- 83%
Reader sentiment
Are you bullish or bearish on GH?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 21 analysts
Buy
Avg price target
201.44 +19.7%
Price target rangecurrent 168.33
Low180.00
Avg201.44
High225.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-25 | Bernstein | -- | BUY | 210.00 |
| 2026-09-20 | Goldman Sachs | -- | BUY | 225.00 |
| 2026-09-18 | Barclays | -- | BUY | 200.00 |
| 2026-09-15 | Craig-Hallum | -- | BUY | -- |
| 2026-09-15 | Piper Sandler | -- | BUY | 193.00 |
| 2026-09-09 | Bernstein | -- | BUY | 210.00 |
| 2026-09-09 | UBS | -- | BUY | 225.00 |
| 2026-09-08 | William Blair | -- | BUY | -- |
| 2026-09-08 | Rothschild & Co Redburn | -- | BUY | 203.00 |
| 2026-09-07 | Goldman Sachs | -- | BUY | 210.00 |
| 2026-09-01 | William Blair | -- | BUY | -- |
| 2026-09-01 | BTIG | -- | BUY | 195.00 |
| 2026-09-01 | Goldman Sachs | -- | BUY | 210.00 |
| 2026-08-25 | William Blair | -- | BUY | -- |
| 2026-08-24 | Piper Sandler | -- | BUY | 193.00 |
| 2026-08-04 | Mizuho Securities | -- | BUY | 200.00 |
| 2026-08-04 | Piper Sandler | -- | BUY | 193.00 |
| 2026-08-04 | Morgan Stanley | -- | BUY | 185.00 |
| 2026-08-04 | Stephens | -- | BUY | 195.00 |
| 2026-08-04 | J.P. Morgan | -- | BUY | 195.00 |
| 2026-08-03 | Stifel | -- | BUY | 180.00 |
| 2026-08-02 | CCORF | -- | BUY | 205.00 |
| 2026-07-31 | TD Cowen | -- | BUY | 210.00 |
| 2026-07-31 | William Blair | -- | BUY | -- |
| 2026-07-31 | Mizuho Securities | -- | BUY | 200.00 |
Quant vs Street three independent views, side by side
StockVane factor grade
C
Momentum strategy signal
Buy
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
✦ Quant Analyst Revision Trend how this is computed
Mixed
1 1
■ Upgrades■ Downgrades
- 1 upgrade vs 1 downgrade among tracked analyst rating changes.
- Most recent: Evercore moved from Hold to Buy on 2026-06-02.
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-06-02 | Evercore | HOLD → BUY | 160.00 |
| 2026-01-05 | Evercore | BUY → HOLD | 105.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-07-30 | After close | ±13.74% | +6.33% (in line) |
| 2026/Q1 | 2026-05-07 | After close | ±11.67% | +3.73% (in line) |
| 2025/Q4 | 2026-02-19 | After close | ±13.88% | -3.08% (in line) |
| 2025/Q3 | 2025-10-29 | After close | ±11.83% | +27.87% (beat) |
| 2025/Q2 | 2025-07-30 | After close | ±15.39% | -9.32% (in line) |
| 2025/Q1 | 2025-04-30 | After close | ±15.94% | +3.47% (in line) |
| 2024/Q4 | 2025-02-20 | After close | ±19.94% | -9.56% (in line) |
| 2024/Q3 | 2024-11-06 | After close | ±13.10% | +13.05% (in line) |
| 2024/Q2 | 2024-08-07 | After close | ±15.26% | -10.87% (in line) |
| 2024/Q1 | 2024-05-09 | After close | ±12.97% | +15.07% (beat) |
| 2023/Q4 | 2024-02-22 | After close | ±18.73% | -12.80% (in line) |
| 2023/Q3 | 2023-11-06 | After close | ±13.12% | -5.41% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 07:03:28 · For reference only, not investment advice and not tailored to your situation.